Abiraterone: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Abiraterone. Educational only — not medical advice.

Labeled uses

Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-sensitive prostate cancer (CSPC)

Source: FDA labeling via NIH DailyMed (set 2ac063f0…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.